[Skip to Content]
[Skip to Content Landing]
October 20, 1956


JAMA. 1956;162(8):833. doi:10.1001/jama.1956.02970250133018

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  I have recently reviewed an article in The Journal (161:511 [June 9] 1956) on postherpetic neuralgia. In this article and other articles are listed the various medicines and surgical procedures to use. However, a very important and highly effective agent was not even discussed, and I have seen practically no mention of the same in any journal. I refer to the use of ganglionic blocking agents, particularly to those that produce a parasympatholytic effect. I would also like to refer readers who are interested to an article published in Northwest Medicine (50:432 [June] 1951), by myself, Reekie, and Sinclair. It was found in this particular series that the ganglionic blocking agent methantheline (Banthine) bromide was most effective. My unpublished data on a series of 15 patients revealed the efficacy of any of the true parasympatholytic agents in herpes zoster or postherpetic neuralgia. One may give

First Page Preview View Large
First page PDF preview
First page PDF preview